Circadian rhythm disorder and anxiety as mental health complications in post-COVID-19

Boiko, D. I.; Skrypnіkov, A. M.; Shkodina, Anastasiia D.; Hasan, Mohammad Mehedi; Ashraf, Ghulam Md; Rahman, Md. Habibur

doi:10.1007/s11356-021-18384-4

Cited by 48 publications

(25 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Due to home isolation, people do not have to wake up for work or study as early as before the pandemic of COVID-19 [57], and later bedtime and wake time were observed in numerous retrospective studies [9,58,59]. Circadian rhythm disorders were associated with increased trait and state anxiety during the pandemic [60]. Moreover, the fear of being infected and other affective issues during COVID-19 caused insomnia, and problems with sleep maintenance may lead to reduced sleep quality.…”

Section: The Impact Of Sleep and Physical Activitymentioning

confidence: 99%

The impact of screen time changes on anxiety during the COVID-19 pandemic: sleep and physical activity as mediators

Qi-yu

Dai

et al. 2022

Sleep Biol. Rhythms

View full text Add to dashboard Cite

Under the burden caused by COVID-19 and rapid lifestyle changes, many people increased their screen time due to psychological needs and social requirements. The current study investigated the relationship between screen time changes and anxiety symptoms during the pandemic of COVID-19. Furthermore, we examined whether sleep and physical activity would mediate the association between screen time changes and anxiety. The self-developed questionnaire was delivered online to collect people's changes in anxiety, sleep patterns, and screen time during COVID-19. 970 participants (74.4% female) with an average age of 23 years were involved in this study. After adjusting demographic variables, the ordinal logistic regression analyses revealed that a significant increase in screen time was linked with anxiety. Slightly increased screen time, slightly and significantly decreased screen time did not predict anxiety symptoms during the pandemic. The level of anxiety was significantly higher among respondents who reported decreased sleep quality. Sleep quality directly mediated the association between screen time changes and anxiety, while sleep latency did not. The longer sleep latency caused by increased screen time would amplify anxiety by affecting sleep quality. In addition, the relationship between screen time changes and anxiety was also mediated by physical activity. We concluded that the fluctuation of screen time in a modest range does not affect the anxiety level substantially. The significantly increased screen time would contribute to poor sleep (including longer sleep latency and worse sleep quality) and lack of physical activity, which would lead to higher levels of anxiety.

show abstract

Section: The Impact Of Sleep and Physical Activitymentioning

confidence: 99%

The impact of screen time changes on anxiety during the COVID-19 pandemic: sleep and physical activity as mediators

Qi-yu

Dai

et al. 2022

Sleep Biol. Rhythms

View full text Add to dashboard Cite

show abstract

“…Astrocytes are also activated during the inflammatory process, a process known as astrogliosis. Aging is a significant risk factor for neurodegeneration [ 50 , 51 , 52 ]. In general, older adults have dysregulated cytokine expression (i.e., increased synthesis of pro-inflammatory cytokines and decreased availability of anti-inflammatory cytokines), resulting in a chronic low-grade inflammatory state.…”

Section: Neurodegeneration Inflammation and Tumorigenesis In The Cent...mentioning

confidence: 99%

A Prospective Viewpoint on Neurological Diseases and Their Biomarkers

et al. 2022

Self Cite

View full text Add to dashboard Cite

Neurodegenerative diseases (NDDs) are disorders that affect both the central and peripheral nervous systems. To name a few causes, NDDs can be caused by ischemia, oxidative and endoplasmic reticulum (ER) cell stress, inflammation, abnormal protein deposition in neural tissue, autoimmune-mediated neuron loss, and viral or prion infections. These conditions include Alzheimer’s disease (AD), Lewy body dementia (LBD), and Parkinson’s disease (PD). The formation of β-sheet-rich aggregates of intra- or extracellular proteins in the CNS hallmarks all neurodegenerative proteinopathies. In systemic lupus erythematosus (SLE), numerous organs, including the central nervous system (CNS), are affected. However, the inflammatory process is linked to several neurodegenerative pathways that are linked to depression because of NDDs. Pro-inflammatory signals activated by aging may increase vulnerability to neuropsychiatric disorders. Viruses may increase macrophages and CCR5+ T cells within the CNS during dementia formation and progression. Unlike medical symptoms, which are just signs of a patient’s health as expressed and perceived, biomarkers are reproducible and quantitative. Therefore, this current review will highlight and summarize the neurological disorders and their biomarkers.

show abstract

“…For example, COVID-19 IgG/IgM rapid test cassette device manufactured by Hangzhou Biotest Biotech Co. L can detect SARS-CoV-2 IgG/IgM antibodies within 5 − 20 min using serum/plasma/blood samples (Dellière et al 2020 ). Similarly, the COVID-19 IgG/IgM Point of Care Rapid test device manufactured by Aytu Biosciences/Orient Gene Biotech can detect SARS-CoV-2 IgG/IgM antibodies within 2 − 10 min (Yang et al 2020 ; Boiko et al 2022 ).…”

Section: Currently Instigated Diagnostic Approachesmentioning

confidence: 99%

COVID-19 diagnostic methods in developing countries

Maniruzzaman

Islam

Ali

et al. 2022

Environ Sci Pollut Res

Self Cite

View full text Add to dashboard Cite

COVID-19 has become one of the few leading causes of death and has evolved into a pandemic that disrupts everyone’s routine, and balanced way of life worldwide, and will continue to do so. To bring an end to this pandemic, scientists had put their all effort into discovering the vaccine for SARS-CoV-2 infection. For their dedication, now, we have a handful of COVID-19 vaccines. Worldwide, millions of people are at risk due to the current pandemic of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2). Despite the lack of clinically authorized antiviral medications and vaccines for COVID-19, clinical trials of many recognized antiviral agents, their combination, and vaccine development in patients with confirmed COVID-19 are still ongoing. This discovery gave us a chance to get immune to this disease worldwide and end the pandemic. However, the unexpected capacity of mutation of the SARS-CoV-2 virus makes it difficult, like the recent SAS-CoV-2 Omicron variant. Therefore, there is a great necessity to spread the vaccination programs and prevent the spread of this dreadful epidemic by identifying and isolating afflicted patients. Furthermore, several COVID-19 tests are thought to be expensive, time-consuming, and require the use of adequately qualified persons to be carried out efficiently. In addition, we also conversed about how the various COVID-19 testing methods can be implemented for the first time in a developing country and their cost-effectiveness, accuracy, human resources requirements, and laboratory facilities. Graphical abstract

show abstract

Circadian rhythm disorder and anxiety as mental health complications in post-COVID-19

Cited by 48 publications

References 38 publications

The impact of screen time changes on anxiety during the COVID-19 pandemic: sleep and physical activity as mediators

The impact of screen time changes on anxiety during the COVID-19 pandemic: sleep and physical activity as mediators

A Prospective Viewpoint on Neurological Diseases and Their Biomarkers

COVID-19 diagnostic methods in developing countries

Contact Info

Product

Resources

About